From: Gail Clement <[log in to unmask]>
Date: Mon, 21 Oct 2013 09:44:45 +0000

Here is the link to the paper on challenges in reproducing scientific
findings, discussed in the keynote for the 2013 Peer Review Congress.
(Sincere  apologies for typos in my previous posting about this.)

John P. A. Ioannidis , Why Most Published Research Findings Are False,
PLos Medicine, 2(8): e124. doi:10.1371/journal.pmed.0020124

http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0020124

FYI, this excellent meeting focuses on ethical and quality issues in
scientific (mostly biomed) publishing. Lots of evidence-based papers
on various publishing issues. The venue is quadrennial --see you there
in 2017?

Gail Clement

-----Original Message-----
From: Ari Belenkiy <[log in to unmask]>
Date: Sat, 19 Oct 2013 21:43:11 -0700

>> Last year researchers at one biotech firm, Amgen, found they could reproduce just six of 53 "landmark" studies in cancer research. Earlier, a group at Bayer, a drug company, managed to repeat just a quarter of 67 similarly important papers.

Does anyone know the details of these results?

Ari Belenkiy

SFU
Canada